SPRR1B and larynx cancer: SPRR family members reported in the literature (SPRR-1, SPRR-2, or SPRR2A) exhibit elevated expression in skin and anal tumors; SPRR1 or SPRR2 expression was decreased in the skin, lung cancer, esophageal cancer, larynx cancer, and the oral cavity [7–11].